ADMA Biologics, Inc. (ADMA) quarterly cash flow statement — complete operating, investing & financing history
ADMA Biologics, Inc. (ADMA) cash flow statement — 19-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | 29.54M | 58.25M | 35.64M | 13.29M | 21.14M | -19.68M | 50.22M | 25.03M | 45.65M | -2.22M | 17.6M | 11.98M | -6.06M | -14.72M | -7.38M | -13.28M | -12.83M | -26.01M | -33.47M | -13.41M |
| Operating CF Margin % | 23.75% | 50.88% | 25.61% | 9.9% | 17.33% | -17.14% | 42.72% | 20.88% | 42.58% | -2.71% | 23.81% | 17.81% | -10.08% | -25.87% | -14.76% | -32.33% | -37.84% | -89.38% | -126.84% | -64.86% |
| Operating CF Growth % | 39.74% | 396.06% | -29.03% | -46.89% | -53.69% | -787.06% | 185.38% | 108.83% | 853.39% | 84.94% | 338.45% | 190.22% | 52.78% | 43.4% | 77.95% | 0.95% | 60.23% | 21.71% | -3.87% | 43.77% |
| Net Income | 37.82M | 45.33M | 49.38M | 36.43M | 34.22M | 26.9M | 111.9M | 35.91M | 32.06M | 17.81M | -17.64M | 2.56M | -6.37M | -6.79M | -12.23M | -14.9M | -13.76M | -25.01M | -16.65M | -17.71M |
| Depreciation & Amortization | 1.78M | 1.84M | 2.05M | 2.02M | 2.06M | 1.97M | 1.94M | 1.94M | 2.27M | 2.11M | 2.11M | 2.81M | 2.1M | 2.52M | 1.94M | 1.86M | 2.07M | 2.18M | 1.52M | 1.42M |
| Stock-Based Compensation | 6.13M | 6.33M | 5.39M | 5.05M | 4.96M | 4.62M | 5.43M | 3.18M | 2.86M | 2.14M | 1.75M | 1.7M | 1.64M | 1.11M | 1.07M | 1.31M | 1.19M | 1.64M | 1.21M | 688.27K |
| Deferred Taxes | 3K | 3.29M | 1.17M | 4.8M | 1.62M | 3.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.34K |
| Other Non-Cash Items | -3.65M | -7.78M | 170K | 2.31M | 1.28M | 154K | -82.78M | 224K | -1.89M | 240K | 27.78M | 1.04M | 1.64M | 689K | 1.85M | 1.93M | -1.72M | 8.32M | 607.8K | 450.28K |
| Working Capital Changes | -12.55M | 9.24M | -22.52M | -37.32M | -23M | -56.75M | 13.72M | -16.22M | 10.34M | -24.52M | 3.6M | 3.87M | -5.06M | -12.25M | -2.89K | -3.49M | -606.91K | -13.14M | -20.15M | 1.74M |
| Change in Receivables | -2.37M | 22.57M | -20.76M | -27.95M | -10.31M | -49.41M | 141K | -20.03M | 19.51M | -22.2M | 3.9M | 5.41M | -10.21M | -11.01M | 5.4M | -2.02M | 6.75M | 2.95M | -8.18M | 3.15M |
| Change in Inventory | -17.21M | -15.63M | -9.8M | -5.2M | -19.28M | -1.95M | 1.57M | 8.01M | -2.08M | -4.83M | -9.79M | -1.34M | 2.2M | -705K | -366.41K | -16.84M | -6.93M | -14.42M | -10.6M | -14.42M |
| Change in Payables | 10.08M | -1.23M | -2.2M | -4.88M | 9.27M | 142K | 3.94M | 1.62M | 0 | 447K | 4.99M | 0 | -871.96K | 0 | -11.97M | 13.81M | 0 | 0 | -4.85M | 11.12M |
| Cash from Investing | -2.26M | 2.4M | -276K | -14.37M | -2.53M | -4.72M | -2.75M | -1.1M | -2.37M | -2.36M | -1.41M | -757K | -872.63K | -1.95M | -3.75M | -3.38M | -3.94M | -2.84M | -3.68M | -2.79M |
| Capital Expenditures | -2.2M | -2.6M | -1.08M | -14.37M | -2.42M | -4.7M | -2.76M | -1.1M | -2.07M | -2.35M | -1.41M | -757K | -872.63K | -1.95M | -3.75M | -3.38M | -3.94M | -2.84M | -3.68M | -2.79M |
| CapEx % of Revenue | 1.77% | 2.27% | 0.78% | 10.7% | 1.99% | 4.09% | 2.35% | 0.92% | 1.93% | 2.87% | 1.9% | 1.13% | 1.45% | 3.42% | 7.5% | 8.23% | 11.62% | 9.77% | 13.93% | 13.48% |
| Acquisitions | -5M | 5M | 1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 4.95M | 0 | -192K | 0 | -105K | -19K | 7K | 0 | -299K | -15K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -29.42M | -10.13M | -9.12M | -27.82M | 48K | -7.13M | -31.03M | -25.47M | -362K | -1.45M | -38.99M | 416K | 240.12K | -650K | 62.74M | -843.79K | -319.04K | 47.27M | 53.82M | 8.2M |
| Debt Issued (Net) | -469K | 124.53M | 549K | -3.27M | -450K | 0 | -30M | -30M | 0 | 0 | -38.66M | 0 | -6.46K | -10K | -9.4K | -9.25K | -9.09K | 51.74M | -8.79K | -8.65K |
| Equity Issued (Net) | -25.02M | -129.6M | -8.47M | -22.65M | 2.06M | -7.23M | -644K | 5.69M | -693K | -2.48M | 8.46K | -208K | 471.55K | -640K | 64.65M | -429.98K | -309.95K | -91.37K | 53.83M | 8.21M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -25.05M | -130.19M | -8.9M | -23.04M | 0 | -7.23M | -644K | 0 | -693K | -2.48M | 0 | -208K | 471.55K | -640K | 0 | -429.98K | -309.95K | -91.37K | 0 | 0 |
| Other Financing | -3.93M | -5.06M | -1.2M | -1.9M | -1.57M | 101K | -382K | -1.16M | 331K | 1.03M | -340.45K | 624K | -224.97K | 0 | -1.89M | -404.56K | 0 | -4.38M | 0 | -2.29K |
| Net Change in Cash | -2.13M | 50.52M | 26.25M | -28.9M | 18.66M | -31.52M | 16.44M | -1.54M | 42.92M | -6.03M | -22.8M | 11.64M | -6.69M | -17.32M | 51.62M | -17.51M | -17.09M | 18.42M | 16.68M | -8M |
| Free Cash Flow | 27.28M | 55.71M | 34.55M | -1.07M | 18.72M | -24.38M | 47.46M | 23.97M | 43.58M | -4.56M | 16.4M | 11.23M | -6.93M | -16.67M | -11.13M | -16.67M | -16.77M | -28.86M | -37.14M | -16.2M |
| FCF Margin % | 21.93% | 48.65% | 24.83% | -0.8% | 15.34% | -21.23% | 40.37% | 20% | 40.66% | -5.58% | 22.19% | 16.69% | -11.53% | -29.29% | -22.26% | -40.56% | -49.46% | -99.15% | -140.78% | -78.34% |
| FCF Growth % | 45.77% | 328.53% | -27.19% | -104.48% | -57.05% | -433.98% | 189.41% | 113.5% | 728.73% | 72.61% | 247.37% | 167.37% | 58.67% | 42.24% | 70.04% | -2.87% | 54.35% | 19.4% | -3.69% | 39.41% |
| FCF per Share | 0.12 | 0.23 | 0.14 | -0.00 | 0.08 | -0.10 | 0.19 | 0.10 | 0.18 | -0.02 | 0.07 | 0.05 | -0.03 | -0.08 | -0.05 | -0.08 | -0.09 | -0.15 | -0.21 | -0.12 |
| FCF Conversion (FCF/Net Income) | 0.78x | 1.29x | 0.72x | 0.36x | 0.62x | -0.73x | 0.45x | 0.70x | 1.42x | -0.12x | -1.00x | 4.67x | 0.95x | 2.17x | 0.60x | 0.89x | 0.93x | 1.04x | 2.01x | 0.76x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 2.75M | 3.25M | 0 | 3.26M | 584K | 0 | 4.62M | 0 | 4.64M | 0 | 0 | 3.46M | 2.53M | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |